PEGalyated liraglutide (QuiaPEG Pharmaceuticals)

N/A

Report date: 2025/01/26 17:44:33

Base Information

Drug NamePEGalyated liraglutide (QuiaPEG Pharmaceuticals)
Drug Alias Namepeg-liraglutide (QuiaPEG Pharmaceuticals)peg-liraglutideQPG-1029
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQuiaPEG Pharmaceuticals AB
China Registration ClassN/A

Develop Information

Active CompaniesQuiaPEG Pharmaceuticals AB
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A